I don't think we need to have all of those answers while research is still developing. But as AI creates increasingly sophisticated ways of understanding disease and supporting treatment decisions, these are questions healthcare organizations will eventually have to answer.

AI governance can look very different once development begins to scale. I look at what happens when models, data and architecture continue to change while the governance process struggles to keep pace.